Tenet Q2 beats expectations; guidance maintained

Tenet Healthcare (NYSE:THC) Q2 results ($M): Revenues: 4,560 (+1.2%).

Net income: (15) (-37.5%); EPS: 0.14 (-39.1%); non-GAAP EBITDA: 657 (+3.6%).

Q3 guidance: Revenue: $4.3B – 4.6B; net income: ($16M) – 21M; non-GAAP EBITDA: $600M – 650M; EPS: ($0.15) – 0.20; non-GAAP EPS: $0.23 – 0.48.

2019 guidance: Revenue: $18.0B – 18.4B (unch); net income: $16M – 116M from $17M – 115M; non-GAAP EBITDA: $2.65B – 2.75B (unch); EPS: $0.15 – 1.09 from $0.16 – 1.10; non-GAAP EPS: $2.08 – 2.59 (unch); cash flow ops: $1.070B – 1.375B (unch).

Previously: Tenet Healthcare EPS beats by $0.12, beats on revenue (Aug. 5)

https://seekingalpha.com/news/3487183-tenet-q2-beats-expectations-guidance-maintained